Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
EXPAREL136.85M76.87%
ZILRETTA30.71M17.25%
iovera°5.67M3.19%
Bupivacaine liposome injectable suspension3.15M1.77%
Royalty revenue1.64M0.92%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
U.S., European Union (E.U.) and United Kingdom (U.K)538.12M79.72%
United States111.1M16.46%
U.S., Canada and Europe19.69M2.92%
Bupivacaine liposome injectable suspension3.34M0.50%
Royalty revenue2.73M0.40%
